264 related articles for article (PubMed ID: 9367418)
1. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
Reilly BD; Mold C
Clin Exp Immunol; 1997 Nov; 110(2):310-6. PubMed ID: 9367418
[TBL] [Abstract][Full Text] [Related]
2. The C4A and C4B isotypic forms of human complement fragment C4b have the same intrinsic affinity for complement receptor 1 (CR1/CD35).
Clemenza L; Isenman DE
J Immunol; 2004 Feb; 172(3):1670-80. PubMed ID: 14734749
[TBL] [Abstract][Full Text] [Related]
3. Differences between C4A and C4B in the handling of immune complexes: the enhancement of CR1 binding is more important than the inhibition of immunoprecipitation.
Gatenby PA; Barbosa JE; Lachmann PJ
Clin Exp Immunol; 1990 Feb; 79(2):158-63. PubMed ID: 2138067
[TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of C4b dimer binding to distinct sites on the C3b/C4b receptor (CR1).
Reilly BD; Makrides SC; Ford PJ; Marsh HC; Mold C
J Biol Chem; 1994 Mar; 269(10):7696-701. PubMed ID: 8125996
[TBL] [Abstract][Full Text] [Related]
5. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
[TBL] [Abstract][Full Text] [Related]
6. Acquired decrease of the C3b/C4b receptor (CR1, CD35) and increased C4d deposits on erythrocytes from ICU COVID-19 patients.
Kisserli A; Schneider N; Audonnet S; Tabary T; Goury A; Cousson J; Mahmoudi R; Bani-Sadr F; Kanagaratnam L; Jolly D; Cohen JH
Immunobiology; 2021 May; 226(3):152093. PubMed ID: 34022670
[TBL] [Abstract][Full Text] [Related]
7. Substitution of two amino acids confers C3b binding to the C4b binding site of CR1 (CD35). Analysis based on ligand binding by chimpanzee erythrocyte complement receptor.
Subramanian VB; Clemenza L; Krych M; Atkinson JP
J Immunol; 1996 Aug; 157(3):1242-7. PubMed ID: 8757632
[TBL] [Abstract][Full Text] [Related]
8. The interaction of soluble human complement receptor type 1 (sCR1, BRL55730) with human complement component C4.
Gibb AL; Freeman AM; Smith RA; Edmonds S; Sim E
Biochim Biophys Acta; 1993 Jan; 1180(3):313-20. PubMed ID: 8422437
[TBL] [Abstract][Full Text] [Related]
9. Identification of complement receptor type 1-related proteins on primate erythrocytes.
Nickells MW; Subramanian VB; Clemenza L; Atkinson JP
J Immunol; 1995 Mar; 154(6):2829-37. PubMed ID: 7876553
[TBL] [Abstract][Full Text] [Related]
10. Zinc ions inhibit factor I-mediated release of CR1-bound immune complexes and degradation of cell-bound complement factors C3b and C4b.
Jepsen HH; Teisner B; Svehag SE
Scand J Immunol; 1990 Apr; 31(4):397-403. PubMed ID: 2139734
[TBL] [Abstract][Full Text] [Related]
11. Complement-dependent binding of C-reactive protein complexes to human erythrocyte CR1.
Mold C; Gurulé C; Otero D; Du Clos TW
Clin Immunol Immunopathol; 1996 Nov; 81(2):153-60. PubMed ID: 8906746
[TBL] [Abstract][Full Text] [Related]
12. Analysis of human C4A and C4B binding to an immune complex in serum.
Reilly BD
Clin Exp Immunol; 1999 Jul; 117(1):12-8. PubMed ID: 10403910
[TBL] [Abstract][Full Text] [Related]
13. The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence.
Holme ER; Veitch J; Johnston A; McKay IC; Whaley K
Rheumatol Int; 1992; 12(5):187-90. PubMed ID: 1290020
[TBL] [Abstract][Full Text] [Related]
14. Complement-mediated adherence of immune complexes to human erythrocytes. Difference in the requirements for C4A and C4B.
Schifferli JA; Hauptmann G; Paccaud JP
FEBS Lett; 1987 Mar; 213(2):415-8. PubMed ID: 3493921
[TBL] [Abstract][Full Text] [Related]
15. The C3b/C4b receptor (CR1, CD35) on erythrocytes: methods for study of the polymorphisms.
Cohen JH; Atkinson JP; Klickstein LB; Oudin S; Subramanian VB; Moulds JM
Mol Immunol; 1999; 36(13-14):819-25. PubMed ID: 10698335
[TBL] [Abstract][Full Text] [Related]
16. Relationship between immune complex binding and release and the quantitative expression of the complement receptor, type 1 (CR1, CD35) on human erythrocytes.
Gibson NC; Waxman FJ
Clin Immunol Immunopathol; 1994 Feb; 70(2):104-13. PubMed ID: 8299225
[TBL] [Abstract][Full Text] [Related]
17. Complement coating of erythrocytes is reduced following their interaction with neutrophils in vitro without loss of complement receptor 1 (CR1).
Imrie HJ; Jones DR
Clin Exp Immunol; 1997 Jul; 109(1):217-22. PubMed ID: 9218847
[TBL] [Abstract][Full Text] [Related]
18. Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement.
Makrides SC; Scesney SM; Ford PJ; Evans KS; Carson GR; Marsh HC
J Biol Chem; 1992 Dec; 267(34):24754-61. PubMed ID: 1447213
[TBL] [Abstract][Full Text] [Related]
19. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
Madi N; Paccaud JP; Steiger G; Schifferli JA
Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
[TBL] [Abstract][Full Text] [Related]
20. Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.
Java A; Liszewski MK; Hourcade DE; Zhang F; Atkinson JP
Mol Immunol; 2015 Oct; 67(2 Pt B):584-95. PubMed ID: 26260209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
